Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing

STAR Protocols(2023)10.1016/j.xpro.2023.102165Source: DataRank Database

Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing is a research paper published in STAR Protocols (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.18)OA: goldTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Michaela Gruber ORCID,María Hernández‐Sánchez ORCID,Gabriela Brunsting Hoffmann ORCID,Kaitlyn Baranowski ORCID,Robert Redd ORCID

Live enrichment

PubMed:37729058 PMC:PMC10510057 OpenAlex:https://openalex.org/W4386822156

NCI NIH HHS

Grant: R01 CA216273

NCI NIH HHS

Grant: P01 CA206978

National Institutes of Health

Grant: 5R01CA216273-04

(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia

European Commission

Grant: 624924

Identification and functional dissection of key genetic events in early chronic lymphocytic leukemia

National Institutes of Health

Grant: 5P01CA206978-05

Comprehensive dissection of the CLL genome and phenome to improve patient outcomes

FWCI

0.18

Citation Percentile

0.5%

Citation Trend

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.xpro.2023.102165

publisherhttps://doi.org/10.1016/j.xpro.2023.102165

publisherhttps://api.elsevier.com/content/article/PII:S2666166723001235?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666166723001235?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37729058

Fields of Study

CRISPR and Genetic EngineeringCytomegalovirus and herpesvirus researchCAR-T cell therapy research0303 health sciences03 medical and health sciencesMiceAnimalsGene EditingCRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsDisease Models, AnimalMutationLymphoproliferative Disorders

MeSH Terms

Gene EditingRNA, Guide, CRISPR-Cas SystemsAnimalsDisease Models, AnimalLymphoproliferative DisordersMutationMiceCRISPR-Cas Systems

Keywords

CRISPRGenome editingCas9BiologyGeneTransduction (biophysics)Stem cellComputational biologyGeneticsFunction (biology)Progenitor cellHaematopoiesisTranscription activator-like effector nucleasemCherryCell biologyGreen fluorescent proteinMolecular biologyCancercell isolationimmunologyHealth SciencesModel OrganismsGene EditingScience (General)RNA, Guide, CRISPR-Cas SystemsLymphoproliferative DisordersQ1-390MiceDisease Models, AnimalMutationProtocolAnimalsCRISPR-Cas Systems

Sustainable Development Goals

SDG 0: Good health and well-being